These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

537 related articles for article (PubMed ID: 32703241)

  • 1. Trem2 deficiency differentially affects phenotype and transcriptome of human APOE3 and APOE4 mice.
    Fitz NF; Wolfe CM; Playso BE; Biedrzycki RJ; Lu Y; Nam KN; Lefterov I; Koldamova R
    Mol Neurodegener; 2020 Jul; 15(1):41. PubMed ID: 32703241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abca1 deficiency affects Alzheimer's disease-like phenotype in human ApoE4 but not in ApoE3-targeted replacement mice.
    Fitz NF; Cronican AA; Saleem M; Fauq AH; Chapman R; Lefterov I; Koldamova R
    J Neurosci; 2012 Sep; 32(38):13125-36. PubMed ID: 22993429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phospholipids of APOE lipoproteins activate microglia in an isoform-specific manner in preclinical models of Alzheimer's disease.
    Fitz NF; Nam KN; Wolfe CM; Letronne F; Playso BE; Iordanova BE; Kozai TDY; Biedrzycki RJ; Kagan VE; Tyurina YY; Han X; Lefterov I; Koldamova R
    Nat Commun; 2021 Jun; 12(1):3416. PubMed ID: 34099706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver X receptor agonist treatment significantly affects phenotype and transcriptome of APOE3 and APOE4 Abca1 haplo-deficient mice.
    Carter AY; Letronne F; Fitz NF; Mounier A; Wolfe CM; Nam KN; Reeves VL; Kamboh H; Lefterov I; Koldamova R
    PLoS One; 2017; 12(2):e0172161. PubMed ID: 28241068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective reduction of astrocyte apoE3 and apoE4 strongly reduces Aβ accumulation and plaque-related pathology in a mouse model of amyloidosis.
    Mahan TE; Wang C; Bao X; Choudhury A; Ulrich JD; Holtzman DM
    Mol Neurodegener; 2022 Feb; 17(1):13. PubMed ID: 35109920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. APOE genotype and sex affect microglial interactions with plaques in Alzheimer's disease mice.
    Stephen TL; Cacciottolo M; Balu D; Morgan TE; LaDu MJ; Finch CE; Pike CJ
    Acta Neuropathol Commun; 2019 May; 7(1):82. PubMed ID: 31113487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of Alzheimer-like synaptic and cholinergic deficits in transgenic mice by human apolipoprotein E depends on isoform, aging, and overexpression of amyloid beta peptides but not on plaque formation.
    Buttini M; Yu GQ; Shockley K; Huang Y; Jones B; Masliah E; Mallory M; Yeo T; Longo FM; Mucke L
    J Neurosci; 2002 Dec; 22(24):10539-48. PubMed ID: 12486146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accumulation of amyloid-β in the brain of mouse models of Alzheimer's disease is modified by altered gene expression in the presence of human apoE isoforms during aging.
    Honda K; Saito Y; Saito H; Toyoda M; Abe R; Saito T; Saido TC; Michikawa M; Taru H; Sobu Y; Hata S; Nakaya T; Suzuki T
    Neurobiol Aging; 2023 Mar; 123():63-74. PubMed ID: 36638682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blocking the apoE/Aβ interaction ameliorates Aβ-related pathology in APOE ε2 and ε4 targeted replacement Alzheimer model mice.
    Pankiewicz JE; Guridi M; Kim J; Asuni AA; Sanchez S; Sullivan PM; Holtzman DM; Sadowski MJ
    Acta Neuropathol Commun; 2014 Jun; 2():75. PubMed ID: 24972680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated approach reveals diet, APOE genotype and sex affect immune response in APP mice.
    Nam KN; Wolfe CM; Fitz NF; Letronne F; Castranio EL; Mounier A; Schug J; Lefterov I; Koldamova R
    Biochim Biophys Acta Mol Basis Dis; 2018 Jan; 1864(1):152-161. PubMed ID: 29038051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trem2 Deletion Reduces Late-Stage Amyloid Plaque Accumulation, Elevates the Aβ42:Aβ40 Ratio, and Exacerbates Axonal Dystrophy and Dendritic Spine Loss in the PS2APP Alzheimer's Mouse Model.
    Meilandt WJ; Ngu H; Gogineni A; Lalehzadeh G; Lee SH; Srinivasan K; Imperio J; Wu T; Weber M; Kruse AJ; Stark KL; Chan P; Kwong M; Modrusan Z; Friedman BA; Elstrott J; Foreman O; Easton A; Sheng M; Hansen DV
    J Neurosci; 2020 Feb; 40(9):1956-1974. PubMed ID: 31980586
    [No Abstract]   [Full Text] [Related]  

  • 12. The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases.
    Krasemann S; Madore C; Cialic R; Baufeld C; Calcagno N; El Fatimy R; Beckers L; O'Loughlin E; Xu Y; Fanek Z; Greco DJ; Smith ST; Tweet G; Humulock Z; Zrzavy T; Conde-Sanroman P; Gacias M; Weng Z; Chen H; Tjon E; Mazaheri F; Hartmann K; Madi A; Ulrich JD; Glatzel M; Worthmann A; Heeren J; Budnik B; Lemere C; Ikezu T; Heppner FL; Litvak V; Holtzman DM; Lassmann H; Weiner HL; Ochando J; Haass C; Butovsky O
    Immunity; 2017 Sep; 47(3):566-581.e9. PubMed ID: 28930663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of TREM2 function increases amyloid seeding but reduces plaque-associated ApoE.
    Parhizkar S; Arzberger T; Brendel M; Kleinberger G; Deussing M; Focke C; Nuscher B; Xiong M; Ghasemigharagoz A; Katzmarski N; Krasemann S; Lichtenthaler SF; Müller SA; Colombo A; Monasor LS; Tahirovic S; Herms J; Willem M; Pettkus N; Butovsky O; Bartenstein P; Edbauer D; Rominger A; Ertürk A; Grathwohl SA; Neher JJ; Holtzman DM; Meyer-Luehmann M; Haass C
    Nat Neurosci; 2019 Feb; 22(2):191-204. PubMed ID: 30617257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-autonomous effects of APOE4 in restricting microglial response in brain homeostasis and Alzheimer's disease.
    Liu CC; Wang N; Chen Y; Inoue Y; Shue F; Ren Y; Wang M; Qiao W; Ikezu TC; Li Z; Zhao J; Martens Y; Doss SV; Rosenberg CL; Jeevaratnam S; Jia L; Raulin AC; Qi F; Zhu Y; Alnobani A; Knight J; Chen Y; Linares C; Kurti A; Fryer JD; Zhang B; Wu LJ; Kim BYS; Bu G
    Nat Immunol; 2023 Nov; 24(11):1854-1866. PubMed ID: 37857825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intermittent hypoxia training enhances Aβ endocytosis by plaque associated microglia via VPS35-dependent TREM2 recycling in murine Alzheimer's disease.
    Wang X; Xie Y; Fan X; Wu X; Wang D; Zhu L
    Alzheimers Res Ther; 2024 Jun; 16(1):121. PubMed ID: 38831312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting apolipoprotein E and N-terminal amyloid β-protein precursor interaction improves cognition and reduces amyloid pathology in Alzheimer's mice.
    Sawmiller D; Koyama N; Fujiwara M; Segawa T; Maeda M; Mori T
    J Biol Chem; 2023 Jul; 299(7):104846. PubMed ID: 37211092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting of nonlipidated, aggregated apoE with antibodies inhibits amyloid accumulation.
    Liao F; Li A; Xiong M; Bien-Ly N; Jiang H; Zhang Y; Finn MB; Hoyle R; Keyser J; Lefton KB; Robinson GO; Serrano JR; Silverman AP; Guo JL; Getz J; Henne K; Leyns CE; Gallardo G; Ulrich JD; Sullivan PM; Lerner EP; Hudry E; Sweeney ZK; Dennis MS; Hyman BT; Watts RJ; Holtzman DM
    J Clin Invest; 2018 May; 128(5):2144-2155. PubMed ID: 29600961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model.
    Fryer JD; Simmons K; Parsadanian M; Bales KR; Paul SM; Sullivan PM; Holtzman DM
    J Neurosci; 2005 Mar; 25(11):2803-10. PubMed ID: 15772340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human APOE4 increases microglia reactivity at Aβ plaques in a mouse model of Aβ deposition.
    Rodriguez GA; Tai LM; LaDu MJ; Rebeck GW
    J Neuroinflammation; 2014 Jun; 11():111. PubMed ID: 24948358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human apolipoprotein E redistributes fibrillar amyloid deposition in Tg-SwDI mice.
    Xu F; Vitek MP; Colton CA; Previti ML; Gharkholonarehe N; Davis J; Van Nostrand WE
    J Neurosci; 2008 May; 28(20):5312-20. PubMed ID: 18480287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.